Skip to main content
Log in

Mucopolysaccharidosis I under enzyme replacement therapy with laronidase—A mortality case with autopsy report

  • Case Report
  • Published:
Journal of Inherited Metabolic Disease

Abstract

There is little information about MPS I-related complications during laronidase therapy. We describe the first autopsy report of a young male MPS I patient who died of infection-induced cardiopulmonary failure following 2 years of weekly treatment with laronidase.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Chan YL, Lin SP, Man TT, et al (2001) Clinical experience in anesthetic management for children with mucopolysaccharidoses: report of ten cases. Acta Paediatr Taiwan 42: 306–308.

    Google Scholar 

  • Chen MR, Lin SP, Hwang HK, et al (2005) Cardiovascular changes in mucopolysaccharidoses in Taiwan. Acta Cardiol 60: 51–53.

    PubMed  Google Scholar 

  • Chuang CK, Lin SP, Chung SF (2001) Diagnostic screening for mucopolysaccharidoses by the dimethylmethylene blue method and two dimensional electrophoresis. Zhonghua Yi Xue Za Zhi (Taipei) 64:15–22.

    CAS  Google Scholar 

  • Cunha DF, Cunha SF, Reis MA, et al (2002) Heart weight and heart weight/body weight coefficient in malnourished adults. Arq Bras Cardiol 78: 382–387.

    Article  PubMed  Google Scholar 

  • Lee-Chen GJ, Lin SP, Tang YF, et al (1999) Mucopolysaccharidosis type I: characterization of novel mutations affecting alpha-L-iduronidase activity. Clin Genet 56: 66–70.

    Article  CAS  PubMed  Google Scholar 

  • Lee-Chen GJ, Lin SP, Chen IS, et al (2002) Mucopolysaccharidosis type I: identification and characterization of mutations affecting α-L-iduronidase activity. J Formos Med Assoc 101: 425–428.

    CAS  PubMed  Google Scholar 

  • Neufeld EF, Muenzer J (2001) The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 3421–3452.

  • Shih SL, Lee YJ, Lin SP, et al (2002) Airway changes in children with mucopolysaccharidoses. Acta Radiol 43: 40–43.

    Article  PubMed  Google Scholar 

  • Wraith JE (2005) The first 5 years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I. Expert Opin Pharmacother 6: 489–506.

    Article  CAS  PubMed  Google Scholar 

  • Wraith JE, Clarke LA, Beck M, et al. (2004) Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase). J Pediatr 144: 581–588.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S.-P. Lin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lin, HY., Lin, SP., Chuang, CK. et al. Mucopolysaccharidosis I under enzyme replacement therapy with laronidase—A mortality case with autopsy report. J Inherit Metab Dis 28, 1146–1148 (2005). https://doi.org/10.1007/s10545-005-0211-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10545-005-0211-x

Keywords

Navigation